FDAnews
www.fdanews.com/articles/206551-medmira-gets-ce-mark-for-its-revealcovid-19-plus-total-antibody-test

MedMira Gets CE Mark for Its REVEALCOVID-19 PLUS Total Antibody Test

February 11, 2022

Nova Scotia, Canada-based MedMira has received a CE mark certification for its REVEALCOVID-19 PLUS Total Antibody Test.

The blood test, which detects the presence of antibodies against the SARS-CoV-2 virus generated by either a previous infection or vaccination, can be completed in less than three minutes, from the moment the blood is drawn until the test provides a result.

MedMira offers its tests in a single pack for individual use and in bulk packaging for standard screening. The test will be available in Europe and any countries accepting the CE mark, the company said.

View today's stories